Welcome to our dedicated page for BWX Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BWX Technologies, Inc. filings document the regulatory record of a NYSE-listed nuclear manufacturing and engineering company serving government and commercial markets. Its disclosures cover operating and financial results, segment performance, backlog-related business activity, risk factors, and material events connected to nuclear propulsion, nuclear fuel, and commercial nuclear operations.
BWXT’s SEC filings also address governance and capital structure. Recent records include proxy materials and annual meeting voting results, board and executive officer matters, registered common stock information, material agreements, and convertible senior notes due 2030 with related subsidiary guarantees.
Melvin Leland D reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director Melvin Leland D received a grant of 13.06 Dividend Equivalent Rights tied to previously awarded restricted stock units. Each right represents a contingent claim on one share of BWXT common stock and will be delivered on the same deferred schedule as the related RSUs, bringing his total such rights to 228.4.
PIASECKI NICOLE WEYERHAEUSER reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Nicole Weyerhaeuser Piasecki received a grant of 6.6 dividend equivalent rights linked to previously awarded restricted stock units. After this award, she holds 53.41 dividend equivalent rights, each representing a contingent right to receive one share of BWXT common stock, delivered proportionately with the related RSUs.
Richardson John M reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director John M. Richardson received a grant of 13.910 Dividend Equivalent Rights on 2026-06-05, bringing his total to 337.870 DERs. These rights accrue on deferred restricted stock units, with each RSU and DER representing a contingent right to receive one share of BWXT common stock, delivered proportionately under his deferral election.
BWX Technologies, Inc. President and CEO Rex D. Geveden sold 10,000 shares of common stock in open-market transactions. The sales occurred on 2026-05-12 at weighted average prices around $203–$207 per share, executed in four separate trades.
The filing states these transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted on 2025-08-11, indicating they were scheduled in advance. Following the transactions, Geveden directly owns 202,491 shares of BWX Technologies common stock.
BWX Technologies, Inc. SVP & Chief Financial Officer Michael Thomas Fitzgerald reported an option-related share sale and exercises. On May 11, 2026, he sold 2,417 shares of common stock in an open-market transaction at $209.25 per share. The filing also shows he exercised employee stock options for a total of 2,417 shares of common stock at exercise prices of $106.64 and $100.83 per share. Following these transactions, he directly holds 6,884 common shares, and continues to hold employee stock options that expire in 2034 and 2035 and vest in three equal annual installments beginning in 2025 and 2026.
BWX Technologies, Inc. submitted a Rule 144 notice reporting the sale of 10,000 shares of Common Stock by Rex D. Geveden. The sale date listed is 02/12/2026 and the filing shows brokerage routing through Charles Schwab & Co., Inc. Shares outstanding are shown as 91,614,649 as of 05/12/2026 (context figure).
BWX Technologies, Inc. SVP & Chief Financial Officer Michael Thomas Fitzgerald exercised employee stock options to acquire 2,826 shares of common stock at $61.70 per share. To satisfy tax obligations, 1,618 shares were withheld at $215.20 per share, a non-market, tax-withholding disposition.
After these compensation-related transactions, he directly holds 6,884 shares of BWX Technologies common stock. The option grant being exercised was part of an award that vests in three equal annual installments beginning February 27, 2024.
BWX Technologies, Inc. reported results from its April 30, 2026 annual meeting of stockholders. Shareholders elected ten directors to one-year terms ending at the 2027 annual meeting, with each nominee receiving substantially more votes for than against.
Stockholders also cast an advisory vote approving 2025 compensation for the company’s named executive officers and ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026.
Bertsch Jan reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director Jan Bertsch received a grant of 762 restricted stock units (RSUs) under the company’s 2020 Omnibus Incentive Plan. Each RSU represents a contingent right to one share of BWXT common stock and vested immediately as part of her board compensation.
Bertsch elected to defer delivery of the shares. According to her deferral election, the vested shares will be delivered in a single lump sum two years after her service on the Board of Directors ends, turning this equity grant into longer-term deferred compensation.